From the Editor-in-Chief
More basic research is needed to understand how various alterations in genes lead to cancers.
by William G. Nelson, MD, PhD
How can Vice President Joe Biden's "Moonshot" initiative make true progress against cancer?
by Kevin McLaughlin
Putting the Immune System in Overdrive | Weighty Matters | A Blood Test for Cancer | Melanoma Risk Increased in Some Lymphoma Survivors | Aspirin Recommended to Reduce Colorectal Cancer Risk | Fine-Tuning Treatments for Triple-Negative Breast Cancer | Don't Get Burned
Your Cancer Guide
Complementary and alternative medicine (CAM) can supplement, but not replace, established cancer treatments.
by Hester Hill Schnipper
Caregiving With Confidence
Follow these tips for keeping your sense of self despite a shift in responsibilities.
by Carly O'Brien
Make the most of email, text messages, Twitter and patient portals.
by Ide Mills
Pain is no gain for patients during or after cancer treatment.
by Sue Rochman
A metastatic melanoma survivor is hopeful but realistic as new treatments become available.
by Jenny Song
Studies focused on individuals rather than large numbers of people can help some patients while advancing knowledge.
by Stephen Ornes
High-deductible health insurance plans can leave cancer patients scrambling to pay the bills for tests and treatments.
by Charlotte Huff
What's The Beef? | Less Stress
Cancer exercise specialist and survivor Julie Goodale offers tips for staying active during and after treatment.
by Ronni Gordon
When a family member wants to stop treatment, addressing post-treatment anxiety and sadness, and considering a clinical trial.
Give patients and their families a break from cancer.
by Maria Wolf
Colleen Bokor, Dana Stewart, Brittany Avin.
Many cancer patients who received genomic testing of their cancers in a clinical trial did not fully understand the purpose of the testing.
by Emma Yasinski
People with cancer are at increased risk of serious complications if they get the flu. Flu shots are safe for this group, and a recent study bolsters evidence of their effectiveness.
by Carly Weeks
A coalition of wives of African leaders, originally dedicated to addressing HIV/AIDS, is now also taking on the growing problem of cancer.
by Bradley D. Miller, PhD
The fall 2019 Cancer Today tells the stories of advocates who are using the internet to amplify their voices, patients who are navigating the world of complementary medicine and researchers who are devising new immunotherapies.
Despite progress in developing new treatment modalities for patients with breast cancer, there is still substantial work to be done in the field.
The immune checkpoint inhibitor Keytruda (pembrolizumab) has been approved for use by some patients with endometrial cancer.
October is Liver Cancer Awareness Month. Here’s a look at the latest statistics and trends.
Follow My Lead
donate to the AACR